Independent fund research. Built on SEC filings.

How we research funds

ETF · Technology Sector · Rbb

LFSC Holdings: What F/m Emerald Life Sciences Innovation ETF Owns

Ticker LFSC · · Holdings as of May 31, 2026

Expense ratio
0.54%$54/yr per $10k
Net assets
$105.1Mall share classes
Holdings
40

Bottom line

What does LFSC hold?

LFSC held 40 positions as of May 31, 2026. Its largest holding is Travere Therapeutics Inc at 7.67% of the fund, and the top 10 positions add up to 54.7%. By asset type it is 100% stocks.

Updated Jul 28, 2026

LFSC top 25 holdings

#HoldingType% of fundValue
1 Travere Therapeutics Inc TVTX Stocks 7.67%$8.1M
2 Cogent Biosciences Inc COGT Stocks 7.53%$7.9M
3 LivaNova PLC LIVN Stocks 7.11%$7.5M
4 Spyre Therapeutics Inc SYRE Stocks 6.41%$6.7M
5 Guardant Health Inc GH Stocks 5.52%$5.8M
6 Mirum Pharmaceuticals Inc MIRM Stocks 4.92%$5.2M
7 Corcept Therapeutics Inc CORT Stocks 4.79%$5.0M
8 United Therapeutics Corp UTHR Stocks 4.16%$4.4M
9 VeraDermics Inc MANE Stocks 3.42%$3.6M
10 Savara Inc SVRA Stocks 3.22%$3.4M
11 Cytokinetics Inc CYTK Stocks 3.16%$3.3M
12 Nektar Therapeutics NKTR Stocks 3.14%$3.3M
13 Trevi Therapeutics Inc TRVI Stocks 3.12%$3.3M
14 Dianthus Therapeutics Inc DNTH Stocks 3.09%$3.2M
15 Axsome Therapeutics Inc AXSM Stocks 2.84%$3.0M
16 Billiontoone Inc BLLN Stocks 2.73%$2.9M
17 TransMedics Group Inc TMDX Stocks 2.68%$2.8M
18 Viridian Therapeutics Inc VRDN Stocks 2.24%$2.3M
19 ICU Medical Inc ICUI Stocks 2.09%$2.2M
20 Corvus Pharmaceuticals Inc CRVS Stocks 1.95%$2.1M
21 Palvella Therapeutics Inc PVLA Stocks 1.95%$2.0M
22 Ceribell Inc CBLL Stocks 1.55%$1.6M
23 Globus Medical Inc GMED Stocks 1.27%$1.3M
24 Xeris Biopharma Holdings Inc XERS Stocks 1.22%$1.3M
25 Bridgebio Pharma Inc BBIO Stocks 1.17%$1.2M

Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 28, 2026

Asset mix

Stocks100.0%

Country exposure

GB7.1%
SG1.0%
US92.0%